The association of homocysteine level with the risk of diabetic nephropathy and diabetic retinopathy in NHANES.

Aims: To examine the association of homocysteine (Hcy) with diabetic nephropathy (DN) and diabetic retinopathy (DR) in a representative United States population. Methods: This was a cross-sectional study using data from participants in the National Health and Nutrition Examination Survey 2005–2006. Metrics including Hcy level, urinary albumin to creatinine ratio, estimated glomerular filtration rate, and retinopathy grading were collected. Multiple logistic regression models were employed to assess the association of Hcy with DN and DR. Results: 630 participants were included in this study. The Hcy level was significantly higher in those with DN and DR than those without DN and DR. Hcy was associated with an increased risk of DN (OR = 1.31, 95% CI 1.18–1.46; P < 0.001). In the fully adjusted model of DN (model II), compared to participants in quartiles 1 of Hcy, the adjusted ORs for participants in quartiles 2–4 were 1.49 (95% CI 0.52–4.26; P = 0.426), 3.81 (95% CI 1.35–10.73; P = 0.015), and 14.08 (95% CI 3.84–51.66; P = 0.001), respectively. Hcy was also associated with an increased risk of DR (OR = 2.260, 95% CI 1.212–4.216; P = 0.014), but this association was non-significant in the fully adjusted model of DR (model II). Conclusions: In diabetic patients, Hcy was associated with increased risk of DN in a non-linear manner. In addition, Hcy was associated with the risk of DR, but the association was attenuated after adjusting for confounders. In the future, Hcy can potentially be used as an early screening indicator for diabetic microvascular complications. [ABSTRACT FROM AUTHOR]